Showing results (21-30 of 204) with videos related to
Sort By:
Pageof 21
Antiviral Therapy|May 29, 2008
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidenceJohannes Wiegand, Dirk Hasenclever, Hans L TillmannSeminars in Liver Disease|May 4, 2011
Understanding the host genetics of chronic hepatitis B and CMark Thursz, Leland Yee, Salim KhakooMolecular Diagnosis & Therapy|September 12, 2013
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapyTzu-Hao Lee, Hans L Tillmann, Keyur PatelThe Journal of Infectious Diseases|January 25, 2018
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma ProgressionSirish Sanaka, George R Kasarala, Hans L TillmannCurrent Gastroenterology Reports|January 27, 2009
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis CHans L Tillmann, Keyur Patel, John G McHutchisonLiver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?Hans L Tillmann, Kalliopi Zachou, George N DalekosMolecular Diagnosis & Therapy|December 4, 2013
A rationalized approach to the treatment of patients infected with hepatitis BNatravis R Cox, Keyur Patel, Hans L TillmannFuture Virology|May 11, 2013
Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challengesMaud Lemoine, Shevanthi Nayagam, Mark ThurszJournal of Hepatology|May 19, 2022
Therapeutic advances in alcohol-associated hepatitisGyongyi Szabo, Mark Thursz, Vijay H ShahDigestive Diseases and Sciences|October 27, 2023
Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF TherapyShiva Poola, MaryKate Kratzer, Kerry Sewell, et al.Pageof 21